In severe or high-grade squamous intraepithelial lesions (SIL) of patients with CC, the increased CEACAM-1 and TIM-3 interaction further suppresses the antitumor activity of CD4+ and CD8+ T cells [215]. The gene discussed is HAVCR2; the disease is squamous cell intraepithelial neoplasia.